The Journal of family practice · 1994
Hepatitis C experience at a community teaching hospital.
Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Woodall D W, Godenick M, Valainis G T
Аннотация
BACKGROUND: The purpose of this study was to review the initial serologic testing experience for hepatitis C (HCV) and physician response at a community teaching hospital.
METHODS: A retrospective chart review was performed for the 59 (5%) HCV-positive patients of 1244 patients who were tested by means of a new enzyme immunosorbent assay (EIA) for HCV antibodies between October 28, 1990, and October 27, 1991.
RESULTS: Physicians identified HCV risk factors, including intravenous drug use (n = 14, 25%) and having received blood products (n = 15, 27%). One half of the patients were not queried about the known risk factors for HCV. The most common reason for ordering an HCV assay was elevated liver enzymes. None of the patients underwent supplementary HCV testing (ie, polymerase chain reaction or recombinant immunoblot assay). In 23 (40%) of the HCV-positive patients, no action was taken by the physician, and 15 (27%) were lost to follow-up. The remaining 18 patients (33%) had further follow-up with laboratory or treatment.
CONCLUSIONS: These results indicate the need for increased physician awareness of risk factors for HCV and improved documentation of these factors in taking patient history. In addition, primary care physicians need to be educated about new laboratory tests and how to interpret test results and when to order supplemental testing.
METHODS: A retrospective chart review was performed for the 59 (5%) HCV-positive patients of 1244 patients who were tested by means of a new enzyme immunosorbent assay (EIA) for HCV antibodies between October 28, 1990, and October 27, 1991.
RESULTS: Physicians identified HCV risk factors, including intravenous drug use (n = 14, 25%) and having received blood products (n = 15, 27%). One half of the patients were not queried about the known risk factors for HCV. The most common reason for ordering an HCV assay was elevated liver enzymes. None of the patients underwent supplementary HCV testing (ie, polymerase chain reaction or recombinant immunoblot assay). In 23 (40%) of the HCV-positive patients, no action was taken by the physician, and 15 (27%) were lost to follow-up. The remaining 18 patients (33%) had further follow-up with laboratory or treatment.
CONCLUSIONS: These results indicate the need for increased physician awareness of risk factors for HCV and improved documentation of these factors in taking patient history. In addition, primary care physicians need to be educated about new laboratory tests and how to interpret test results and when to order supplemental testing.
Предметные рубрики MeSH
AdolescentAdultAgedAged, 80 and overAlanine TransaminaseEvaluation Studies as TopicFemaleHIV SeropositivityHepacivirusHepatitis AntibodiesHepatitis CHepatitis C AntibodiesHospital Bed Capacity, 500 and overHospitals, CommunityHospitals, TeachingHumansImmunoenzyme TechniquesMaleMedical AuditMiddle AgedRetrospective StudiesRisk FactorsSubstance Abuse, Intravenous